Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aastrom Biosciences, Inc.
Collaboration agreement signed for German bone graft clinical trial
May 14th, 2003
Aastrom Biosciences, Inc., (ASTM) announced that through its wholly owned subsidiary Zellera AG, it has signed an agreement with Mathys Medical, Ltd., (Mathys), located in Bettlach, Switzerland, and Bergmannsheil University Clinic (University), located in Bochum, Germany, to begin the first collaborative clinical trial using the company's Tissue Repair Cells (TRCs) for bone graft applications. If successful, the study may lead to an alternative to the current, highly invasive standard of treatment in the multibillion dollar bone graft market. The bone graft clinical study will use Aastrom's proprietary bone-forming TRCs in combination with Mathys'...
Source: Biotech Week (2003-05-14)
|
